NYC Cancels Macy's Thanksgiving Day Parade; Russia Recruits 55k Volunteers For COVID-19 Vaccine Trials: Live Updates
These 3 Penny Stocks Could Double (Or More), Says BTIG
Euro Firm on Positive Market Sentiment & Good Data, Can Face Troubles in Future
Futures Surge On Monday Merger Mania, Fresh Vaccine Hopes
AUD/USD calm ahead of RBA minutes
Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will
Monday’s Pre-Market: Here’s What You Need To Know Before The Market Opens
UK Presses Ahead, China Strikes Out at German Pork Producers, and Moody's Weighs on Turkey
AZ resumes UK coronavirus vaccine trial
Galapagos Pops 9% On Positive Result Of Novesa Trial
Molecular Completes Manufacturing For Covid-19 Drug, Plans Nov. Human Trial
Japanese Yen Soft amid Risk Appetite, Manages to Hold Ground Against Some Rivals
Regeneron, Sanofi’s Dupixent Nabs Breakthrough Tag For Esophagus Disease
Johnson & Johnson Kicks Off Phase 2 Covid-19 Vaccine Trial In Spain - Report
Eli Lilly’s Migraine Drug Delivers Pain Freedom In New Phase 3 Study
Gilead Inks $21B Immunomedics Deal, Adding Trodelvy To Its Oncology Arsenal
Pfizer CEO: Our Covid-19 Vaccine Could Be Ready For Americans By Year-End
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
Czech Republic Suffers Another Record Jump In COVID-19 Cases As Florida Deaths Drop To Just 8: Live Updates
China Slaps German Pork With Export Ban As African Swine Fever Infects First Wild Boar
Pfizer, BioNTech Propose Expansion Of Phase 3 Covid-19 Vaccine Trial
AstraZeneca Resumes Late-Stage Covid-19 Vaccine Trials In UK
Weekly Market Review: Volatility Continues During Short Week
Merck Kicks Off Human Covid-19 Vaccine Trial In Belgium- Report
Gilead Sciences Close To Inking $20B Immunomedics Deal- Report
UBS Downgrades Expedia To Hold On Travel Demand Concerns; Shares Fall
Merck starts recruitment for Covid-19 vaccine trial
Pfizer, BioNTech propose expanding CovidD-19 vaccine trial to 44,000 volunteers
AstraZeneca resumes UK trials of Covid-19 vaccine halted by patient illness
Tactical Asset Allocation – September 2020